Elutia Inc. (NASDAQ:ELUT) Shares Acquired by AIGH Capital Management LLC

AIGH Capital Management LLC lifted its holdings in shares of Elutia Inc. (NASDAQ:ELUT - Free Report) by 22.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,074,675 shares of the company's stock after purchasing an additional 564,233 shares during the quarter. Elutia comprises approximately 3.6% of AIGH Capital Management LLC's investment portfolio, making the stock its 11th biggest position. AIGH Capital Management LLC owned 8.90% of Elutia worth $11,499,000 as of its most recent SEC filing.

Separately, Geode Capital Management LLC raised its position in Elutia by 50.3% in the third quarter. Geode Capital Management LLC now owns 188,408 shares of the company's stock valued at $718,000 after purchasing an additional 63,047 shares during the period. 74.03% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, Director Highcape Capital, L.P. purchased 420,000 shares of the business's stock in a transaction on Monday, February 3rd. The shares were bought at an average price of $2.50 per share, for a total transaction of $1,050,000.00. Following the acquisition, the director now directly owns 9,520,232 shares in the company, valued at $23,800,580. This trade represents a 4.62 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 40.80% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Separately, Cantor Fitzgerald restated an "overweight" rating and set a $8.00 price target on shares of Elutia in a research report on Friday, March 7th.

Remove Ads

Elutia Stock Down 0.7 %

NASDAQ:ELUT traded down $0.02 on Thursday, reaching $2.75. 12,288 shares of the company's stock were exchanged, compared to its average volume of 46,717. The firm has a market capitalization of $112.03 million, a price-to-earnings ratio of -1.05 and a beta of 0.96. Elutia Inc. has a 52-week low of $2.28 and a 52-week high of $5.24. The business has a fifty day moving average of $2.94 and a 200-day moving average of $3.49.

About Elutia

Elutia Inc, a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as pacemakers and internal defibrillators.